GenNext Technologies-preview

Gnxtech

GenNext Technologies

Private

Half Moon Bay, CaliforniaHealthcare & Life Scienceshttps://gnxtech.com

Last Round

Grant

Apr 1, 2023

Total Funding Raised

$16.8M

Momentum Score

50 /100

Company Overview

GenNext Technologies is a biotechnology company that provides instrumentation, software, and services to pharmaceutical researchers investigating biopharmaceutical structure, interactions, folding, aggregation, formulation, and delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts, Hardware + Subscription

AI Layer

Non-AI

Keywords

hydroxyl radical protein footprintingHRPFprotein structure analysisprotein footprintinghigher-order structureHOSstructural biologylife science instrumentsautomated protein analysisdrug discovery toolscontract research servicesCRObiotech equipmentmass spectrometry workflowbiotherapeutics developmentAI protein model validationmonoclonal antibody analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GenNext Technologies Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

GenNext Technologies Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Apr 1, 2023
Grant	Oct 26, 2022
Grant	Mar 24, 2022
Grant	May 1, 2021
Grant	Apr 28, 2021
Grant	Apr 1, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Joshua Sharp

Chief Technology Officer

Executive Team

GenNext Technologies Investors

Notable investors and investment history

Investor	Rounds
National Institute of General Medical Sciences	Grant

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 24, 2026
Monthly visitors grew 41% MoM.
May 7, 2025
Partnered with Thermo Fisher Scientific to develop protein analysis workflows.

View all signals

GenNext Technologies Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

GenNext Technologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GenNext Technologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersHalf Moon Bay, California

Employee Range19

Year Founded2016

Last FundingApr 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.